Top Suppliers:I want be here
Related CAS#:
202825-46-5 133865-89-1
1147299-69-1 1147299-71-5
133866-14-5 2748522-33-8
202464-88-8 144143-96-4
2763365-40-6 122517-78-6
1049367-93-2 1158522-08-7
940364-43-2 134104-43-1
131615-57-1 6906-52-1
1208404-08-3 930439-75-1
1018584-77-4 1375289-11-4

202825-46-5

202825-46-5 structure
202825-46-5 structure
  • Name: Safinamide Mesylate
  • Chemical Name: Safinamide mesylate salt
  • CAS Number: 202825-46-5
  • Molecular Formula: C18H23FN2O5S
  • Molecular Weight: 398.449
  • Catalog: Biochemical Inhibitor Metabolism MAO inhibitor
  • Create Date: 2018-05-01 08:00:00
  • Modify Date: 2024-01-02 13:28:50
  • Safinamide mesylate mesylate (FCE 26743 mesylate; EMD 1195686 mesylate) is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 µM) over MAO-A (IC50=580 µM)[1]. Safinamide mesylate also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8 µM) than at resting (IC50=262 µM) potentials. Safinamide mesylate has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke etc.al[2][3].
Name Safinamide mesylate salt
Synonyms (S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide
N-{4-[(3-Fluorobenzyl)oxy]benzyl}-L-alaninamide methanesulfonate (1:1)
Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2S)-, methanesulfonate (1:1)
(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide,methanesulfonic acid
PNU-151774E,NW-1015
Safinamide mesylate
(S)-2-(4-(3-fluorobenzyloxy)benzylamino)propanamide,methanesulfonate
(S)-(+)-2-[[4-(3-Fluorobenzoxy)benzyl]amino]propanamide
FCE-28073(R-isomer),PNU-151774E,NW-1015
Description Safinamide mesylate mesylate (FCE 26743 mesylate; EMD 1195686 mesylate) is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 µM) over MAO-A (IC50=580 µM)[1]. Safinamide mesylate also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8 µM) than at resting (IC50=262 µM) potentials. Safinamide mesylate has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke etc.al[2][3].
Related Catalog
Target

MAO-B:98 nM (IC50)

MAO-A:580 nM (IC50)

In Vitro Safinamide mesylate (1-300 µM) reduces the amplitude of the peak sodium currents in a concentration-dependent manner. When currents are stimulated to a Vtest of +10 mV from a Vh of -110 mV, the IC50 value was 262 µM. When the holding potential is depolarized to -53 mV, the inhibitory effect of Safinamide mesylate with a lower IC50 value (8 µM) in rat cortical neurons[1].
In Vivo Safinamide mesylate (intraperitoneal injection; 90 mg/kg; once daily; 14 days) treatment prior to MCAO significantly ameliorates MCAO-caused cerebral infarction volume, neurological deficit, disruption of the brain-blood barrier (BBB), and impairs expression of tight junction protein occludin and ZO-1 in mice[3]. Safinamide mesylate (intraperitoneal injection; 5 mg/kg, 15 mg/kg and 30 mg/kg) dose dependently inhibits the veratridine-induced GABA release and Glu release in vivo. At the dose 30 mg/kg,  Safinamide mesylate prevents the effect of veratridine both on Glu (treatment F1,8=1.31; time×treatment interaction F8,64=2.4) and GABA (treatment F1,8=4.04; time F8,64=3.76, time×treatment interaction F8,64=2.83) release. Safinamide mesylate causes a slight, albeit not significant, reduction of veratridine-stimulated Glu release at 0.5 mg/kg and full inhibition at 5 and 15 mg/kg in rat[3].
References

[1]. Leonetti F, et al. Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase. J Med Chem, 2007, 50(20), 4909-4916.

[2]. C Caccia, et al.Safinamide: from molecular targets to a new anti-Parkinson drug. Neurology. 2006 Oct 10;67(7 Suppl 2):S18-23.

[3]. Michele Morari, et al. Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia.J Pharmacol Exp Ther. 2018 Feb;364(2):198-206.
Boiling Point 476.7ºC at 760 mmHg
Melting Point 210° (dec)
Molecular Formula C18H23FN2O5S
Molecular Weight 398.449
Flash Point 242.1ºC
Exact Mass 398.131165
PSA 127.10000
LogP 4.04410
Vapour Pressure 2.98E-09mmHg at 25°C
Symbol GHS05 GHS06 GHS09
GHS05, GHS06, GHS09
Signal Word Danger
Hazard Statements H301-H318-H400
Precautionary Statements P273-P280-P301 + P310-P305 + P351 + P338
Hazard Codes C
RIDADR UN 2811 6.1 / PGIII
HS Code 2924299090
HS Code 2924299090
Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Chemsrc provides CAS#:202825-46-5 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 202825-46-5 | Chemsrc address: https://www.chemsrc.com/en/baike/683764.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved